Physicochemical Properties
| Molecular Formula | C6H4FN3O3S |
| Molecular Weight | 217.1777 |
| Exact Mass | 216.995 |
| CAS # | 91366-65-3 |
| PubChem CID | 122067 |
| Appearance | Yellow to green solid powder |
| Density | 1.7±0.1 g/cm3 |
| Boiling Point | 408.8±55.0 °C at 760 mmHg |
| Melting Point | 145-146ºC |
| Flash Point | 201.0±31.5 °C |
| Vapour Pressure | 0.0±1.0 mmHg at 25°C |
| Index of Refraction | 1.632 |
| LogP | 0.11 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 1 |
| Heavy Atom Count | 14 |
| Complexity | 317 |
| Defined Atom Stereocenter Count | 0 |
| InChi Key | XROXHZMRDABMHS-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C6H4FN3O3S/c7-3-1-2-4(14(8,11)12)6-5(3)9-13-10-6/h1-2H,(H2,8,11,12) |
| Chemical Name | 7-fluoro-2,1,3-benzoxadiazole-4-sulfonamide |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References |
[1]. New fluorogenic reagent having halogenobenzofurazan structure for thiols: 4-(aminosulfonyl)-7-fluoro-2, 1, 3-benzoxadiazole. Analytical chemistry, 1984, 56(13): 2461-2464. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~125 mg/mL (~575.56 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (9.58 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.08 mg/mL (9.58 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 4.6045 mL | 23.0224 mL | 46.0448 mL | |
| 5 mM | 0.9209 mL | 4.6045 mL | 9.2090 mL | |
| 10 mM | 0.4604 mL | 2.3022 mL | 4.6045 mL |